TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer

T-cell receptor alternate reading frame protein (TARP) is a 58-residue protein over-expressed in prostate and breast cancer. We investigated TARP peptide vaccination's impact on the rise in PSA (expressed as Slope Log(PSA) or PSA Doubling Time (PSADT)), validated tumor growth measures, and tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Wood, Lauren V., Fojo, Antonio, Roberson, Brenda D., Hughes, Meghan S. B., Dahut, William, Gulley, James L., Madan, Ravi A., Arlen, Philip M., Sabatino, Marianna, Stroncek, David F., Castiello, Luciano, Trepel, Jane B., Lee, Min-Jung, Parnes, Howard L., Steinberg, Seth M., Terabe, Masaki, Wilkerson, Julia, Pastan, Ira, Berzofsky, Jay A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
MIATA Compliant Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007958/
https://ncbi.nlm.nih.gov/pubmed/27622067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1197459
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados